Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

JB Chemicals & Pharmaceuticals Ltd

+ Add to Watchlist

JBCP:IN

239.20 INR 6.30 2.57%

As of 07:06:06 ET on 05/22/2015.

Snapshot for JB Chemicals & Pharmaceuticals Ltd (JBCP)

Open: 246.45 Day's Range: 238.05 - 246.80 Volume: 215,531
Previous Close: 245.50 52wk Range: 136.55 - 268.50 1-Yr Rtn: +56.33%

Stock Chart for JBCP

No chart data available.
  • JBCP:IN 239.20
  • 1D
  • 1M
  • 1Y
245.50
Interactive JBCP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JBCP

Current P/E Ratio (ttm) 20.2027
Estimated P/E(03/2016) 15.4273
Relative P/E vs. SENSEX -
Earnings Per Share (INR) (ttm) 11.8400
Est. EPS (INR) (03/2016) 15.5050
Est. PEG Ratio -
Market Cap (M INR) 20,286.13
Shares Outstanding (M) 84.81
30 Day Average Volume 380,925
Price/Book (mrq) 2.0391
Price/Sale (ttm) 1.8101
Dividend Indicated Gross Yield 1.67%
Cash Dividend (INR) 4.0000
Dividend Ex-Date
5 Year Dividend Growth 24.57%
Next Earnings Announcement 05/20/2016
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JBCP

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for JBCP

J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.

Jyotindra Bhagwanlal ModyChairman/Managing DirectorPranabh Dinesh ModyPresident/Exec Dir:Operations
Bhavesh JoshiChief Financial OfficerP K SinghPresident:Global Business
More Company Profile & Key Executives for JBCP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil